Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $7.68, but opened at $8.00. Anavex Life Sciences shares last traded at $7.88, with a volume of 120,328 shares traded. Analyst Upgrades and Downgrades Several equities research analysts recently […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and AUD/BSD (NASDAQ:VXRT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, risk and profitability. Insider & Institutional Ownership 33.4% of Anavex […]
Anavex Life Sciences (NASDAQ:AVXL – Free Report) and Dyadic International (NASDAQ:DYAI – Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of current […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) saw some unusual options trading activity on Friday. Stock investors bought 34,063 call options on the stock. This represents an increase of 1,964% compared to the typical daily volume of 1,650 call options. Analyst Upgrades and Downgrades Several analysts recently commented on the stock. HC Wainwright raised […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 15,900,000 shares, a growth of 10.6% from the April 30th total of 14,380,000 shares. Based on an average trading volume of 1,000,000 shares, the days-to-cover ratio […]